Skip to main content

Pediatrix Medical Group, Inc.

corporate_fare Company Profile

Pediatrix Medical Group, Inc.

MD·NYSE·Industrial Applications And Services·CIK 0000893949

Pediatrix Medical Group, Inc. is a leading provider of physician services, specializing in newborn, maternal-fetal, and other pediatric subspecialty care. The company operates a national network of approximately 2,295 affiliated physicians across 37 states as of December 31, 2025. This network includes 1,350 physicians who provide neonatal clinical care, primarily in hospital-based neonatal intensive care units (NICUs), for premature or medically complicated babies. Additionally, over 475 affiliated physicians offer maternal-fetal and obstetrical medical care to expectant mothers with complicated pregnancies, often in areas where the company's neonatal physicians practice. The network also features other pediatric subspecialists, with over 230 physicians providing pediatric intensive care, 220 physicians delivering hospital-based pediatric care, and 20 physicians performing pediatric surgical care. During 2024, Pediatrix completed plans to exit almost all of its affiliated office-based practices, excluding maternal-fetal medicine, and also exited its primary and urgent care service line. The company's neonatal care services involve affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians staffing and managing clinical activities at over 360 NICUs in 32 states. Pediatrix Medical Group, Inc. was incorporated in Florida in 2007.

Pediatrix Medical Group, Inc. (NYSE:MD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for MD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for MD spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Pediatrix 10-Q Details Q3: $501.4M Revenue, $147.2M Buybacks, Term Loan Due Feb 2027
  • Pediatrix Q3 Adjusted EPS $0.72; Full-Year EBITDA Guidance Raised to $290M-$300M
  • Pediatrix Posts Q3 EPS of 59 Cents
  • Pediatrix Q2 2026: Adjusted EPS $0.63 Beats Estimates, Full-Year EBITDA Guidance Reaffirmed
  • Pediatrix Q2 Earnings Beat with $0.63 Adjusted EPS; Reaffirms 2026 EBITDA Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.91B
Net Income
$165.39M
Diluted EPS
$1.94
Op. Cash Flow
$271.09M
Operating Income
$208.81M
Cash & Equivalents
$375.24M
Debt / Equity
0.00×
Net Margin
8.6%
Shares Outstanding
82.98M sh
Source: 10-K · filed 2026-02-19 · accession 0001193125-26-058074

Short Interest & Short Volume

5.03 days to cover

FINRA reported short interest of 3,546,600 shares in MD as of the October 30, 2026 settlement, a 18.9% decrease from the prior period — about 5.0 days to cover at its recent average daily volume. On November 20, 2026, 36.6% of MD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,546,600 shares as of October 30, 2026
Change vs prior period▼ 18.9%
Days to cover5.03 at avg daily volume of 705,586
Daily short volume (FINRA facilities)36.6% of 322,643 shares on November 20, 2026
5-day average short volume54.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$30.22
52-week range · as of 2026-10-29 $16.9 – $30.22
Market cap
$2.36B
Volume
791K (1.1× avg)
3-mo avg 695.3K
Live data · 2026-11-22 05:19 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MD - Latest Insights

MD
Oct 29, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.60
Real-time Price: $30.22 info
Change: +$1.62 (+6%) info
Market Cap: $2.361B info
MD
Oct 29, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.60
Real-time Price: $30.22 info
Change: +$1.62 (+6%) info
Market Cap: $2.361B info
MD
Oct 29, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.60
Real-time Price: $30.22 info
Change: +$1.62 (+6%) info
Market Cap: $2.361B info
MD
Aug 04, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $25.05
Real-time Price: $30.22 info
Change: +$5.17 (+21%) info
Market Cap: $2.361B info
MD
Aug 04, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.68
Real-time Price: $30.22 info
Change: +$4.54 (+18%) info
Market Cap: $2.361B info
MD
Aug 04, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $25.68
Real-time Price: $30.22 info
Change: +$4.54 (+18%) info
Market Cap: $2.361B info
MD
Jul 15, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $23.92
Real-time Price: $30.22 info
Change: +$6.30 (+26%) info
Market Cap: $2.361B info
MD
May 07, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.93
Real-time Price: $30.22 info
Change: +$7.29 (+32%) info
Market Cap: $2.361B info
MD
May 05, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $30.22 info
Change: +$7.81 (+35%) info
Market Cap: $2.361B info
MD
May 05, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $30.22 info
Change: +$7.81 (+35%) info
Market Cap: $2.361B info
MD
May 05, 2026, 6:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $30.22 info
Change: +$7.81 (+35%) info
Market Cap: $2.361B info
MD
Mar 27, 2026, 6:50 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $20.79
Real-time Price: $30.22 info
Change: +$9.43 (+45%) info
Market Cap: $2.361B info
MD
Mar 26, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $20.98
Real-time Price: $30.22 info
Change: +$9.24 (+44%) info
Market Cap: $2.361B info
MD
Feb 19, 2026, 7:00 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $20.65
Real-time Price: $30.22 info
Change: +$9.57 (+46%) info
Market Cap: $2.361B info
MD
Feb 19, 2026, 6:50 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.65
Real-time Price: $30.22 info
Change: +$9.57 (+46%) info
Market Cap: $2.361B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets